CVSA reports Q4 non-GAAP EPS of $2.09, topping estimates by $0.20, with revenue at $501.38M.
Covista (CVSA) shares climbed over 10% Friday after the healthcare education provider posted stronger-than-expected fourth-quarter earnings. The company reported non-GAAP EPS of $2.09, exceeding estimates by $0.20, while revenue reached $501.38M, $14.83M above projections.
Analysts had anticipated lower earnings, with consensus estimates centered around $1.89 per share. The company also provided robust full-year 2027 guidance, signaling confidence in sustained growth.
The earnings beat and optimistic outlook drove the stock’s sharp intraday gain, reflecting investor optimism about Covista’s performance trajectory.